Jake Turrentine, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Abbvie
    Topic:
    Rinvoq
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Amgen
    Topic:
    Atopic Dermatitis
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Psoriasis
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Discover Dermatology, LLC
    Topic:
    Multiple diseases
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    Doximity
    Topic:
    health care tech
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Eli Lilly
    Topic:
    Atopic Dermatitis
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Galderma
    Topic:
    Nemluvio
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Medicus Pharma, LTD
    Topic:
    Basal cell carcinoma
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    Moderna Therapeutics
    Topic:
    vaccines
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Objective Health
    Topic:
    multiple
    Date added:
    03/08/2026
    Date updated:
    08/12/2026
    Relationship end date:
    06/30/2026

Pages

Return to Qualderm Partners Grand Rounds